HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA on the "Dirty Dozen"

This article was originally published in The Rose Sheet

Executive Summary

FDA on the "Dirty Dozen": In response to a list issued by CPC and consumer advocate Ralph Nadar citing 12 consumer products containing carcinogens, FDA says it is unaware of any scientific data that indicates the products listed "pose a threat to public health if used as intended." Alberto-Culver, manufacturer of Alberto VO5 conditioners (one of the products cited in the list), says that the formula listed "was replaced some time ago by an improved formulation." In addition, the company maintains that all its ingredients are used in formulations "in the proportions recommended and approved" by cosmetic safety boards and government agencies. Alberto-Culver products also are "manufactured under and comply with strict quality control standards," the firm says. Bristol-Myers Squibb, another Dirty Dozen target, says that all its products, including Clairol Nice n' Easy, have been "tested extensively by scientific experts"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel